Abstract
Development of effective therapies for brain disorders has been hampered by a lack of translational cognitive testing methods. We present the first example of using the identical touchscreen-based cognitive test to assess mice and humans carrying disease-related genetic mutations. This new paradigm has significant implications for improving how we measure and model cognitive dysfunction in human disorders in animals, thus bridging the gap towards effective translation to the clinic.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Animals
-
Case-Control Studies
-
Cognition Disorders / diagnosis*
-
Cognition Disorders / genetics
-
DNA Copy Number Variations
-
Diagnosis, Computer-Assisted
-
Female
-
Guanylate Kinases / genetics*
-
Humans
-
Male
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Middle Aged
-
Mutation
-
Photic Stimulation
-
Protein Biosynthesis
-
Schizophrenia / diagnosis
-
Schizophrenia / genetics
-
Sequence Homology, Amino Acid
-
Spatial Learning
-
Tumor Suppressor Proteins / genetics*
-
User-Computer Interface
-
Young Adult
Substances
-
Tumor Suppressor Proteins
-
DLG2 protein, human
-
Guanylate Kinases